Medicus Pharma Ltd. (MDCX) IPO - S-1 Filing, Stock & Insider Activity
Medicus Pharma Ltd. IPO - Status & S-1 Filing
- Ticker: MDCX
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-11-19
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001997296 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Medicus Pharma Ltd. (MDCX) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-04. 2 Form 8-K material event filings were reported by MDCX in the last 90 days. InsiderAlpha tracks every MDCX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Medicus Pharma Ltd. (MDCX)
Medicus Pharma Ltd. trades under the ticker MDCX. InsiderAlpha tracks 38 primary SEC Form 4 filings from 14 reporting insiders for MDCX since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001997296 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 13 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-04 |
Recent MDCX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| James P. Quinlan | Chief Financial Officer | M - Option exercise | 125.0K | $0.81 | $101K | SEC | |
| James P. Quinlan | Chief Financial Officer | M - Option exercise | 20.0K | $2.75 | $55K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Medicus Pharma Ltd. (MDCX). Updated in real time as new filings are submitted to the SEC.
Most-Active MDCX Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Raza Bokhari | 1 | - |
| Barry Fishman | 1 | - |
| Edward J. Brennan | 1 | - |
| Carolyn F. Bonner | 1 | - |
| William Ashton | 1 | - |
Recent MDCX Form 8-K Material Events
- - Item 5.07, 9.01 [SEC]
- - Item 1.01, 2.03, 3.01, 9.01 [SEC]
- - Item 1.01, 3.01, 9.01 · Financing · neutral [SEC]
Medicus Pharma increased its at-the-market (ATM) equity offering program from $15.3 million to $50 million through an amendment to its existing equity distribution agreement with Maxim Group and Yorkville Securities. As of the filing date, the company has raised approximately $11 - - Item 3.02, 9.01 · Financing · negative [SEC]
Medicus Pharma completed a series of equity sales totaling 4,471,038 common shares for approximately $3.85 million under a Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors. The company used proceeds to prepay a portion of outstanding debentures. This represents si
Recent Insider Filings
- - Andrew Alasdair Smith (Chief Operating Officer)
- - Cathy McMorris Rodgers (Director)
- - Ajay Raju (Director)
- - Faisal Mehmud (Chief Medical Officer)
- - Sara R. May (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MDCX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
MDCX Insider Trading - FAQ
- What is the latest insider trade for MDCX?
- Medicus Pharma Ltd. (MDCX) had 13 insider filings in the last 90 days, with the most recent on 2026-06-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying MDCX stock?
- 0 insider purchases of MDCX were filed in the last 90 days.
- How many insiders are selling MDCX stock?
- 0 insider sales of MDCX were filed in the last 90 days.
- Where can I see MDCX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks MDCX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $MDGL MADRIGAL PHARMACEUTICALS, INC.
- $MGRX MANGOCEUTICALS, INC.
- $MLYS Mineralys Therapeutics, Inc.
- $MODD Modular Medical, Inc.
- $MRUS Merus N.V.
- $MTVA MetaVia Inc.
- $NAMS NewAmsterdam Pharma Co N.V.
- $NUWE Nuwellis, Inc.
- $OBIO Orchestra BioMed Holdings, Inc.
- $ONCO Onconetix, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live MDCX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.